- ScreenPro’s (SCRN) wholly-owned subsidiary, Naturevan Nutrition Ltd. has shipped its first batch of vitamin products to Amazon U.S.A.
- ScreenPro plans to expand to Amazon Canada shortly
- This new vertical truly diversifies ScreenPro’s product offerings and exposes the Company to new revenue and profit avenues
- ScreenPro (SCRN) is up 16.67 per cent, trading at $0.035 per share as of noon ET
ScreenPro’s (SCRN) wholly-owned subsidiary, Naturevan Nutrition, has shipped its first batch of vitamin products to Amazon U.S.A.
ScreenPro’s Chairman and CEO, Andrew Ryu, called this a significant milestone for the company.
“With plans to expand to Amazon Canada shortly, this new vertical truly diversifies ScreenPro’s product offerings and exposes the company to new revenue and profit avenues. With the U.S.A vitamin market gaining popularity for health and wellness, management believes entering the vitamin market and selling on a major eCommerce platform such as Amazon will give great returns. We are close to execution and will share more developments soon.”
Citing recent U.S. Dietary Supplements Market data, the company’s leadership predicts that Naturevan will exceed its exceptions.
The North American vitamin market is leading dietary supplements and accounted for 30.8 per cent of the revenue share last year. Valued at $151 billion in 2021, the American vitamin market is expected to increase at a compound annual growth of 8.9 per cent to 2030.
ScreenPro Security is a medical technology company providing turnkey screening solutions through proprietary alerting software.
ScreenPro (SCRN) is up 16.67 per cent, trading at $0.035 per share as of noon ET.
